PLAT
PLAT (Plasminogen Activator, Tissue Type) is a protein coding gene. Diseases associated with PLAT include Lethal Hydranencephaly-Diaphragmatic Hernia Syndrome andThrombophilia, Familial, Due To Decreased Release Of Tissue Plasminogen Activator. Among its related pathways are Cell adhesion_ECM remodeling and Apelin signaling pathway. Gene Ontology annotations related to this gene include serine-type endopeptidase activity. An important paralog of the gene is HGFAC.
Full Name
Plasminogen Activator, Tissue Type
Function
Converts the abundant, but inactive, zymogen plasminogen to plasmin by hydrolyzing a single Arg-Val bond in plasminogen. By controlling plasmin-mediated proteolysis, it plays an important role in tissue remodeling and degradation, in cell migration and many other physiopathological events. During oocyte activation, plays a role in cortical granule reaction in the zona reaction, which contributes to the block to polyspermy (By similarity).
Biological Process
Blood coagulationManual Assertion Based On ExperimentTAS:ProtInc
Cellular response to dexamethasone stimulusIEA:Ensembl
Cellular response to follicle-stimulating hormone stimulusIEA:Ensembl
Cellular response to luteinizing hormone stimulusIEA:Ensembl
FibrinolysisTAS:Reactome
Negative regulation of fibrinolysis1 PublicationIC:ComplexPortal
Negative regulation of plasminogen activation1 PublicationIC:ComplexPortal
Negative regulation of proteolysisManual Assertion Based On ExperimentIDA:BHF-UCL
Plasminogen activationManual Assertion Based On ExperimentIDA:UniProtKB
Platelet-derived growth factor receptor signaling pathwayManual Assertion Based On ExperimentIBA:GO_Central
Positive regulation of ovulationIEA:Ensembl
Prevention of polyspermyISS:UniProtKB
Protein modification processManual Assertion Based On ExperimentTAS:ProtInc
ProteolysisManual Assertion Based On ExperimentIBA:GO_Central
Regulation of synaptic plasticityIEA:Ensembl
Response to cAMPIEA:Ensembl
Response to fatty acidIEA:Ensembl
Response to hypoxiaIEA:Ensembl
Smooth muscle cell migrationManual Assertion Based On ExperimentIBA:GO_Central
Synaptic transmission, glutamatergicIEA:Ensembl
Trans-synaptic signaling by BDNF, modulating synaptic transmissionIEA:Ensembl
Cellular response to dexamethasone stimulusIEA:Ensembl
Cellular response to follicle-stimulating hormone stimulusIEA:Ensembl
Cellular response to luteinizing hormone stimulusIEA:Ensembl
FibrinolysisTAS:Reactome
Negative regulation of fibrinolysis1 PublicationIC:ComplexPortal
Negative regulation of plasminogen activation1 PublicationIC:ComplexPortal
Negative regulation of proteolysisManual Assertion Based On ExperimentIDA:BHF-UCL
Plasminogen activationManual Assertion Based On ExperimentIDA:UniProtKB
Platelet-derived growth factor receptor signaling pathwayManual Assertion Based On ExperimentIBA:GO_Central
Positive regulation of ovulationIEA:Ensembl
Prevention of polyspermyISS:UniProtKB
Protein modification processManual Assertion Based On ExperimentTAS:ProtInc
ProteolysisManual Assertion Based On ExperimentIBA:GO_Central
Regulation of synaptic plasticityIEA:Ensembl
Response to cAMPIEA:Ensembl
Response to fatty acidIEA:Ensembl
Response to hypoxiaIEA:Ensembl
Smooth muscle cell migrationManual Assertion Based On ExperimentIBA:GO_Central
Synaptic transmission, glutamatergicIEA:Ensembl
Trans-synaptic signaling by BDNF, modulating synaptic transmissionIEA:Ensembl
Cellular Location
Secreted, extracellular space
Involvement in disease
Increased activity of TPA results in increased fibrinolysis of fibrin blood clots that is associated with excessive bleeding. Defective release of TPA results in hypofibrinolysis that can lead to thrombosis or embolism.
PTM
The single chain, almost fully active enzyme, can be further processed into a two-chain fully active form by a cleavage after Arg-310 catalyzed by plasmin, tissue kallikrein or factor Xa.
Differential cell-specific N-linked glycosylation gives rise to two glycoforms, type I (glycosylated at Asn-219) and type II (not glycosylated at Asn-219). The single chain type I glycoform is less readily converted into the two-chain form by plasmin, and the two-chain type I glycoform has a lower activity than the two-chain type II glycoform in the presence of fibrin.
N-glycosylation of Asn-152; the bound oligomannosidic glycan is involved in the interaction with the mannose receptor.
Characterization of O-linked glycan was studied in Bowes melanoma cell line.
Differential cell-specific N-linked glycosylation gives rise to two glycoforms, type I (glycosylated at Asn-219) and type II (not glycosylated at Asn-219). The single chain type I glycoform is less readily converted into the two-chain form by plasmin, and the two-chain type I glycoform has a lower activity than the two-chain type II glycoform in the presence of fibrin.
N-glycosylation of Asn-152; the bound oligomannosidic glycan is involved in the interaction with the mannose receptor.
Characterization of O-linked glycan was studied in Bowes melanoma cell line.
View more
Anti-PLAT antibodies
+ Filters
Loading...
Target: PLAT
Host: Mouse
Antibody Isotype: IgG
Specificity: Mouse
Clone: CBYC-P421
Application*: E, WB
Target: PLAT
Host: Mouse
Antibody Isotype: IgG
Specificity: Mouse, Rat
Clone: CBYJT-1562
Application*: E, WB
Target: PLAT
Host: Mouse
Antibody Isotype: IgG3, κ
Specificity: Mouse, Rat
Clone: H27B6
Application*: E, EC, WB
Target: PLAT
Host: Mouse
Antibody Isotype: IgG
Specificity: Mouse, Rat
Clone: CBYJT-1561
Application*: E, IH, WB
Target: PLAT
Host: Mouse
Antibody Isotype: IgG1
Specificity: Mouse
Clone: CBYJT-1560
Application*: E, WB
Target: PLAT
Host: Mouse
Antibody Isotype: IgG
Specificity: Human, Pig
Clone: CBYJT-1559
Application*: E, WB
Target: PLAT
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBYJT-1558
Application*: E, WB
Target: PLAT
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: T-1
Application*: WB, E, IH, C
Target: PLAT
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: CBYJT-1556
Application*: E, IP, IH, WB
Target: PLAT
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: CBYJT-1555
Application*: WB, IH
Target: PLAT
Host: Mouse
Antibody Isotype: IgM
Specificity: Human
Clone: CBYJT-1554
Application*: E
Target: PLAT
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: 2A153
Application*: IA, E, IO, WB
Target: PLAT
Host: Rabbit
Antibody Isotype: IgG
Specificity: Human
Clone: 32B1
Application*: E, F
Target: PLAT
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: CBYC-P422
Application*: E, WB
Target: PLAT
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: 3H3
Application*: P
Target: PLAT
Host: Mouse
Antibody Isotype: IgM
Specificity: Human
Clone: 2 VPA
Application*: E
More Infomation
Hot products 
-
Rat Anti-C5AR1 Recombinant Antibody (8D6) (CBMAB-C9139-LY)
-
Mouse Anti-ACTN4 Recombinant Antibody (V2-6075) (CBMAB-0020CQ)
-
Mouse Anti-ADIPOR1 Recombinant Antibody (V2-179982) (CBMAB-A1368-YC)
-
Rat Anti-CD300A Recombinant Antibody (172224) (CBMAB-C0423-LY)
-
Mouse Anti-FOXA3 Recombinant Antibody (2A9) (CBMAB-0377-YC)
-
Mouse Anti-BCL6 Recombinant Antibody (CBYY-0435) (CBMAB-0437-YY)
-
Mouse Anti-ACKR3 Recombinant Antibody (V2-261265) (CBMAB-C1023-LY)
-
Mouse Anti-A2M Recombinant Antibody (V2-178822) (CBMAB-A0036-YC)
-
Mouse Anti-G6PD Recombinant Antibody (13B331) (CBMAB-G1553-LY)
-
Mouse Anti-ANXA7 Recombinant Antibody (A-1) (CBMAB-A2941-YC)
-
Rat Anti-AChR Recombinant Antibody (V2-12500) (CBMAB-0990-CN)
-
Mouse Anti-F11R Recombinant Antibody (402) (CBMAB-0026-WJ)
-
Mouse Anti-BIRC3 Recombinant Antibody (16E63) (CBMAB-C3367-LY)
-
Mouse Anti-DMPK Recombinant Antibody (CBYCD-324) (CBMAB-D1200-YC)
-
Mouse Anti-B2M Recombinant Antibody (CBYY-0050) (CBMAB-0050-YY)
-
Mouse Anti-EMP3 Recombinant Antibody (CBFYE-0100) (CBMAB-E0207-FY)
-
Mouse Anti-AKR1C3 Recombinant Antibody (V2-12560) (CBMAB-1050-CN)
-
Mouse Anti-ATP1A2 Recombinant Antibody (M7-PB-E9) (CBMAB-A4013-YC)
-
Mouse Anti-AMACR Recombinant Antibody (CB34A) (CBMAB-CA034LY)
-
Mouse Anti-ARIH1 Recombinant Antibody (C-7) (CBMAB-A3563-YC)
For Research Use Only. Not For Clinical Use.
(P): Predicted
* Abbreviations
- AActivation
- AGAgonist
- APApoptosis
- BBlocking
- BABioassay
- BIBioimaging
- CImmunohistochemistry-Frozen Sections
- CIChromatin Immunoprecipitation
- CTCytotoxicity
- CSCostimulation
- DDepletion
- DBDot Blot
- EELISA
- ECELISA(Cap)
- EDELISA(Det)
- ESELISpot
- EMElectron Microscopy
- FFlow Cytometry
- FNFunction Assay
- GSGel Supershift
- IInhibition
- IAEnzyme Immunoassay
- ICImmunocytochemistry
- IDImmunodiffusion
- IEImmunoelectrophoresis
- IFImmunofluorescence
- IGImmunochromatography
- IHImmunohistochemistry
- IMImmunomicroscopy
- IOImmunoassay
- IPImmunoprecipitation
- ISIntracellular Staining for Flow Cytometry
- LALuminex Assay
- LFLateral Flow Immunoassay
- MMicroarray
- MCMass Cytometry/CyTOF
- MDMeDIP
- MSElectrophoretic Mobility Shift Assay
- NNeutralization
- PImmunohistologyp-Paraffin Sections
- PAPeptide Array
- PEPeptide ELISA
- PLProximity Ligation Assay
- RRadioimmunoassay
- SStimulation
- SESandwich ELISA
- SHIn situ hybridization
- TCTissue Culture
- WBWestern Blot
Online Inquiry



